NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q4 2025 | 35.00% |
| Q3 2025 | -42.39% |
| Q2 2025 | 57.67% |
| Q1 2025 | -226.08% |
| Q4 2024 | -82.97% |
| Q3 2024 | 440.00% |
| Q2 2024 | 9.09% |
| Q1 2024 | 21.43% |
| Q4 2023 | -7.69% |
| Q3 2023 | 35.00% |
| Q2 2023 | 4.76% |
| Q1 2023 | -90.91% |
| Q4 2022 | -29.87% |
| Q3 2022 | 50.18% |
| Q2 2022 | 10.53% |
| Q1 2022 | -5.56% |
| Q4 2021 | 18.18% |
| Q3 2021 | 12.00% |
| Q2 2021 | -19.05% |
| Q1 2021 | 19.23% |
| Q4 2020 | -227.46% |
| Q3 2020 | 94.03% |
| Q2 2020 | -358.62% |
| Q1 2020 | 71.57% |
| Q4 2019 | -240.00% |
| Q3 2019 | 28.57% |
| Q2 2019 | 30.00% |
| Q1 2019 | -42.86% |
| Q4 2018 | 47.50% |
| Q3 2018 | -70.21% |
| Q2 2018 | 9.62% |
| Q1 2018 | 17.46% |
| Q4 2017 | -12.50% |
| Q3 2017 | 15.15% |
| Q2 2017 | -57.14% |
| Q1 2017 | -133.33% |
| Q4 2016 | -5354.55% |
| Q3 2016 | 77.40% |
| Q2 2016 | -175.47% |
| Q1 2016 | 53.10% |